检索

The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension

Valieva Z., Valeeva E., Glukhova S., Martynyuk T., Chazova I.

(Rus)

卷 16, 编号 4 (2019)

Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy

Oshchepkova E., Avalyan A., Rogoza A., Gorieva S., Saidova M., Chazova I.

(Rus)

卷 13, 编号 3 (2016)

Zhernakova Y., Chazova I.

(Rus)

卷 14, 编号 4 (2017)

Features of the use of torasemide in arterial hypertension

Baryshnikova G., Chorbinskajya S.

(Rus)

卷 18, 编号 4 (2021)

Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project

Bontsevich R., Vovk Y., Gavrilova A., Batishcheva G., Goncharova N., Elizarova I., Ketova G., Barysheva V., Bikkinina G., Myronenko O.

(Rus)

卷 14, 编号 2 (2017)

Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)

Oshchepkova E., Lazareva N., Chazova I.

(Rus)

卷 18, 编号 3 (2021)

Clinical features and course of arterial hypertension in patients with its various forms

Denisova A., Esaulova T., Solntseva T., Sivakova O., Chazova I.

(Rus)

Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project

Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Ebzeeva E., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Barysheva V., Ketova G., Maksimov M., Osipova O.

(Rus)

卷 17, 编号 3 (2020)

Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease

Chazova I., Nevzorova V., Ambatiello L., Brodskaia T., Oshchepkova E., Belevskii A., Zhernakova J., Aisanov Z., Ovcharenko S., Chuchalin A.

(Rus)

Possibilities of treatment of patients with resistant arterial hypertension

Shugushev Z., Maximkin D., Ryumina A.

(Rus)

卷 18, 编号 2 (2021)

Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project

Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Krotkova I., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Ketova G., Barysheva V., Maksimov M., Osipova O.

(Rus)

Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment

Denisova A., Solntseva T., Sivakova O., Chazova I.

(Rus)

卷 13, 编号 3 (2016)

Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology

Dolgova E., Fedorovich A., Martynyuk T., Rogoza A., Chazova I.

(Rus)

卷 12, 编号 4 (2015)

Myocardial ischemia in patients with pulmonary arterial hypertension

Arkhipova O., Martyniuk T., Valeeva E., Ryabykina G., Samoylenko L., Sergienko V., Chazova I.

(Rus)

Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system

Mozheyko M., Eregin S., Vigdorchik A., Klimovskaia I., Riahi F., Hughes D.

(Rus)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension

Sobolev A., Ryabykina G., Kozhemyakina E.

(Rus)

Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension

Arkhipova O., Gratsianskaya S., Martynyuk T.

(Rus)

卷 14, 编号 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.

(Rus)

卷 16, 编号 3 (2019)

Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice

Gratsianskaya S., Valieva Z., Zorin A., Martynyuk T.

(Rus)

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment

Arkhipova O., Martynyuk T.

(Rus)

卷 14, 编号 2 (2017)

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine

Kuznetsova E., Glukhova S., Martynyuk T., Nakonechnikov S., Chazova I.

(Rus)

卷 13, 编号 3 (2016)

Workplace hypertension": focus on emotional and personality traits in patients

Ostroumova O., Pervichko E., Zinchenko Y.

(Rus)

卷 17, 编号 3 (2020)

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

卷 13, 编号 2 (2016)

Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy

Ostroumova O., Kochetkov A., Lopukhina M.

(Rus)

卷 13, 编号 4 (2016)

Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension

Shchelkova G., Zairova A., Danilov N., Rogoza A., Chazova I.

(Rus)

卷 15, 编号 1 (2018)

Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2

Statsenko M., Turkina S., Titarenko M.

(Rus)

卷 13, 编号 4 (2016)

The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea

Elfimova E., Zairova A., Andrievskaya M., Bogieva R., Rogoza A., Litvin A.

(Rus)

Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case

Bykov A., Arkhipov M., Klimusheva N., Iofin A., Krokhalev V.

(Rus)

卷 18, 编号 2 (2021)

Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction

Alekseeva T., Litvin A., Elfimova E., Mikhailova O., Larina V., Shpot E., Podzolkov V., Chazova I.

(Rus)

Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus

Zhernakova J., Chazova I.

(Rus)

Fleita is a Russian randomized, open-label, multicenter, comparative program for the evaluation of the efficacy and safety of the fixed combination drug Tarka (ABBOTT Laboratories, USA) versus optional sustained-release antihypertensive drugs in the treatment of patients with arterial hypertension and cognitive disorders (stepwise strategy)

Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension

Aksenova A., Oshchepkova E., Orlovsky A., Chazova I.

(Rus)

卷 16, 编号 4 (2019)

Consensus on patients with hyperuricemia and high cardiovascular risk treatment

Chazova I., Zhernakova J., Kisliak O., Nedogoda S., Podzolkov V., Oshchepkova E., Medvedeva I., Mironova O., Blinova N.

(Rus)

卷 6, 编号 4 (2009)

Chazova I., Ostroumova O.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial

Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.

Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin

Ezhov M., Yezhov M.

Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity

Zheleznova E., Zhernakova Y., Chazova I., Rogoza A., Zairova A., Shariya M., Yarovaya E., Orlovsky A., Blinova N., Azimova M., Gorieva S., Konosova I.

(Rus)

卷 15, 编号 3 (2018)

Features of diurnal blood pressure profile, arterial stiffness and left ventricular structure and function in patients with arterial hypertension, prediabetes and type 2 diabetes mellitus

Fendrikova A., Gutova S., Skibitsky V., Skibitsky A.

(Rus)

The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension

Blood pressure level and arterial stiffness parameters role in prediction of the antihypertensive therapy efficacy escape phenomenon

Mikhailova O., Elfimova E., Litvin A., Rogoza A.

(Rus)

卷 14, 编号 3 (2017)

Calcineurin inhibitors and arterial hypertension in recipients of solid organs

Kosmacheva E., Martirosyan S., Lepshokova M., Babich A.

(Rus)

卷 14, 编号 4 (2017)

Modern concepts of the relationship between obesity and erectile dysfunction in patients with arterial hypertension

Alekseeva T., Litvin A.

(Rus)

卷 14, 编号 2 (2017)

Clinical efficacy of sympathetic denervation of renal arteries in patients with resistant arterial hypertension as part of annual prospective follow-up

Gapon L., Mikova E., Savelyeva N., Kolunin G., Zherzhova A.

(Rus)

卷 13, 编号 4 (2016)

The control of blood pressure level as the prevention of cognitive impairment

Melnik M., Afonicheva I., Kazyulin A.

(Rus)

卷 12, 编号 3 (2015)

Treatment of hypertension in overweight patients

Kukes V., Anikin G., Andreevskaya E., Ashurkova E.

(Rus)

卷 12, 编号 1 (2015)

Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach

Zhernakova Y., Sharipova G., Chazova I.

(Rus)

卷 12, 编号 2 (2015)

Chazova E., Martyniuk T.

(Rus)

Perindopril - angiotensin-converting enzyme inhibitor is approved for usage

Napalkov D.

(Rus)

Place of angiotensin receptor blockers in the treatment of hypertension according to the latest recommendations of the 2013 European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) for the treatment of hypertension

Peculiarity of medical management of patients with arterial hypertension after liver transplantation

Kosmacheva Y., Babich A.

(Rus)

卷 11, 编号 3 (2014)

Phylogentic theory of pathology. Common phylogenetic features in the pathogenesis of essential arterial hyperntesion and insulin resistance syndrome

Titov V.

(Rus)

卷 11, 编号 2 (2014)

The benefits of candesartan usage in the treatment of arterial hypertension

Ostroumova O., Bondarets O., Guseva T.

(Rus)

卷 11, 编号 2 (2014)

The functional state of microcirculatory vessels in patients with arterial hypertension I-II degree with different degrees of cardiovascular risk

Mordvinova E., Oschepkova E., Fedorovich A., Rogoza A.

(Rus)

卷 11, 编号 1 (2014)

Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass

Yahontov D., Derisheva D., Gulyaeva L.

(Rus)

卷 10, 编号 4 (2013)

Chukaeva I., Solovieva M., Litvinova S.

卷 10, 编号 2 (2013)

Factors influencing compliance with lifestyle modification in an organized population

Alekseeva T., Ogarkov M., Skripchenko A., Yankin M.

卷 10, 编号 1 (2013)

The diagnosis and treatment of patients with arterial hypertension and chronic obstructive inflammatory pulmonary diseases (Guidelines of the Russian Medical Society on Arterial Hypertension and the Russian Respiratory Society)

Chazova I., Chuchalin A., Zykov K., Ratova L.

卷 6, 编号 2 (2009)

Combined low-dose therapy of arterial hypertension

Stryuk R.

卷 18, 编号 4 (2021)

Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology

Murkamilov I., Fomin V., Yusupov F., Sabirov I.

(Rus)

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with 2 and 3 grade of arterial hypertension in the Russian clinical study VICTORY II

Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galyavich A., Rotar’ O., Khaisheva L., Kameneva T.

(Rus)

Obesity as a risk factor of contrast-induced acute kidney injury in patients with arterial hypertension and stable coronary artery disease

Mironova O., Sivakova O., Fomin V.

(Rus)

卷 17, 编号 3 (2020)

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease

Mironova O., Fomin V.

(Rus)

卷 18, 编号 4 (2021)

Blood pressure variability, endothelial dysfunction, and C-reactive protein levels in arterial hypertension in combination with coronary artery disease

Musikhina N., Petelina T., Gapon L., Kostousova A.

(Rus)

卷 16, 编号 3 (2019)

The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus

Zhernakova J., Chazova I., Blinova N.

(Rus)

卷 16, 编号 3 (2019)

Features of arterial hypertension patients with discrepancies in vectorcardiographic and echocardiographic conclusions about the presence of left ventricular hypertrophy [Original Article]

Blinova E., Sakhnova T., Chaykovskaya O., Saidova M., Ryabykina G.

(Rus)

卷 6, 编号 3 (2009)

Performance of the Program of prevention and treatment of arterial hypertension in Ukraine (1999-2007)

Sirenko Y.

卷 6, 编号 4 (2009)

Diuretics in treatment of patients with arterial hypertension

Chazova I., Ratova L.

卷 6, 编号 3 (2009)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.

Ratova L., Chazova I.

Evaluation of subclinical cardiotoxicity in patients with breast cancer and arterial hypertension in two regimens of anthracycline-containing chemotherapy

Avalyan A., Oshchepkova E., Saidova M., Shitov V., Glazkova E., Stenina M., Chazova I.

(Rus)

卷 15, 编号 3 (2018)

The progression of carotid vascular remodeling risk factors in patients with arterial hypertension

Pavlova O., Korobko I., Nechesova T., Liventseva M., Zatoloka N., Kovsh E., Ogurtsova S., Mrochek A.

(Rus)

Arterial hypertension in patients with non-specific aortoarteritis

Chikhladze N.

(Rus)

卷 14, 编号 3 (2017)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations

Ostroumova O., Piksina G., Smolyarchuk E., Pavleeva E., Bondarets O.

(Rus)

卷 14, 编号 1 (2017)

Dihydropyridine calcium antagonists: conscious choice

Ostroumova O., Vikentev V., Abrosimov A., Smoliarchuk E.

(Rus)

卷 14, 编号 1 (2017)

Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study)

Efremova Y., Oshchepkova E., Zhernakova Y., Chazova I., Iarovaia E., Shalnova S., Rotar O., Konradi A., Shliakhto E., Boitsov S.

(Rus)

卷 12, 编号 4 (2015)

A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial

Ostroumova O., Fomina V., Smolyarchuk E.

(Rus)

卷 12, 编号 4 (2015)

Using meldonium to improve adaptation of patients with hypertension and pre-diabetes to influence of heat

Smirnova M., Svirida O., Ageev F., Fofanova T., Vitsenya M., Mikhaylov G.

(Rus)

卷 12, 编号 1 (2015)

Central and humoral mechanisms for arterial hypertension in women

Podzolkov V., Bragina A., Rodionova J., Koloda J.

(Rus)

卷 12, 编号 1 (2015)

Medical and social risk factors for arterial hypertension in coal miners

Indukaeva E., Makarov S., Ogarkov M.

(Rus)

卷 12, 编号 2 (2015)

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension

Zavyrylina I., Arkhipova O., Saidova M., Danylov N., Martynyuk T., Chazova I.

(Rus)

Arterial hypertension and brain damage. New targets of therapy

Yanishevskiy S., Mirnaya D., Andreyev R.

(Rus)

卷 11, 编号 3 (2014)

Pleiotropic features of dihydropyridine calcium channel antagonists

Anikin G.

(Rus)

卷 11, 编号 3 (2014)

Why occurrence of arterial hypertension with age becomes frequent?

Poseliugina O., Poseliugina E., Al-Galban N.

(Rus)

卷 11, 编号 1 (2014)

The telmisartan and amlodipine combination in the treatment of hypertension

Shehyan G., Yalymov A., Schikota A., Zadionchenko V., Varentsov S.

(Rus)

卷 10, 编号 4 (2013)

Clinico-pharmacological aspects of metoprolol use

Anikin G., Chernova I., Vinokurov V.

卷 10, 编号 2 (2013)

Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii

Chazova I., Martynyuk T.

卷 10, 编号 1 (2013)

Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension

Ostroumova O., Pervichko E.

卷 9, 编号 4 (2012)

The availability of a home tonometer as a factor that increases therapy compliance in outpatients with arterial hypertension

Smirnova M., Tsygareishvili E., Ageyev F., Svirida O., Kuzmina A., Fofanova T.

卷 6, 编号 2 (2009)

Obstructive sleep apnea syndrome

Litvin A., Chazova I.

卷 18, 编号 3 (2021)

Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders

Perepech N., Chazova I., Zhernakova J.

(Rus)

The place of fixed antihypertensive drugs in modern therapy of arterial hypertension

Pinchuk T., Orlova N.

(Rus)

Primary hyperaldosteronism as a possible cause of resistant arterial hypertension

Chikhladze N.

(Rus)

卷 17, 编号 1 (2020)

Evidence base regarding target levels of arterial pressure in patients after a stroke: focus on a geriatric population

Ostroumova O., Cherniaeva M.

(Rus)

卷 16, 编号 2 (2019)

Orthostatic reactions and cognitive dysfunctions in elderly and senile patients with arterial hypertension

Atyunina I., Oschepkova E., Rogoza A., Lazareva N.

(Rus)

卷 16, 编号 1 (2019)

Obesity and hypertension: the role of criteria

Tsygankova D., Krivoshapova K., Maksimov S., Indukaeva E., Shapovalova E., Artamonova G., Barbarash O.

(Rus)

卷 6, 编号 4 (2009)

Rationale for the use of sartans in patients with arterial hypertension

Stryuk R.

Metabolic syndrome

Mychka V., Chazova I., Mychka V., Chazova I.